The New England journal of medicine, vol. 372, no. 25, pp. 2387-2397 Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP Cannon, C P, Blazing, M A, Giugliano, R P, McCagg, A, White, J A, Theroux, P, Darius, H, Lewis, B S, Ophuis, T O, Jukema, J W, De Ferrari, G M, Ruzyllo, W, De Lucca, P, Im, K, Bohula, E A, Reist, C, Wiviott, S D, Tershakovec, A M, Musliner, T A, Braunwald, E, Califf, R M, IMPROVE-IT Investigators & Clemmensen, P M 2015, ' Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes ', The New England Journal of Medicine, vol. 372, no. 25, pp. 2387-2397 . https://doi.org/10.1056/NEJMoa1410489 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (25), pp.2387-97. ⟨10.1056/NEJMoa1410489⟩ New England Journal of Medicine, 372(25), 2387-2397 New England journal of medicine, 372(25), 2387-2397. Massachussetts Medical Society
Mortensen, U, Nielsen-Kudsk, J E, Søndergaard, H, Jakobsen, P, Jensen, BS, Schmitz, O & Nielsen, T T 2006, ' Effect of the oral hypoglycaemic sulfonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication ', Diabet. Med., vol. 23(3), pp. 327-30 .